Early Access Program for ALXN1840 in Patients With Wilson Disease

Summary

This is an open-label, single-arm, multi-center EAP, designed to provide early access to ALXN1840 for eligible patients with WD.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications